XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled TrialWOS

    Chen Yao
    Chen Yao
    Hui Han
    Hui Han
    Kaijiang Yu
    Kaijiang Yu
    Luyi Liu
    Luyi Liu
    Ying Xu
    Ying Xu
    Zhongmin Liu
    Zhongmin Liu
    Ying Wang
    Ying Wang
    Zhuang Ma
    Zhuang Ma
    Cited by: 4|Bibtex|15|

    Critical care medicine, 2019, Pages 1

    Abstract:

    In critically ill patients with severe community-acquired pneumonia, XueBiJing injection led to a statistically significant improvement in the primary endpoint of the pneumonia severity index as well a significant improvement in the secondary clinical outcomes of mortality, duration of mechanical ventilation and duration of ICU stay.This ...More
    Your rating :
    0

     

    Tags
    Comments